OpGen Reports Third Quarter 2023 Financial Results and Provides Business Update Total revenue for the first nine months of 2023 was approximately $2.35 million compared to approximately $1.89 million in the first nine months of 2022Implemented certain cash management initiatives,...

OpGen Enters Into Distribution Agreement for Unyvero in the U.S. with Fisher Healthcare Fisher Healthcare, a part of Thermo Fisher Scientific, will become the non-exclusive national laboratory distribution partner alongside OpGen, Inc.’s direct sales in the U.S. for the Unyvero A50...